Y. Hattori

V-shaped relationship between HbA1c and all-cause mortality in the elderly with type 2 diabetes

Y. Yazaki, R. Nishimura, M. Komatsu, 2014 .

Heteroplasmic mitochondrial DNA 3310 mutation in NADH dehydrogenase subunit 1 associated with type 2 diabetes, hypertrophic cardiomyopathy, and mental retardation in a single patient.

Y. Hattori, T. Ehara, K. Nakajima, 2003, Diabetes care.

Cilnidipine, the N- and L-type calcium channel antagonist, reduced on 24-h urinary catecholamines and C-peptide in hypertensive non-insulin-dependent diabetes mellitus.

S. Takeda, M. Irie, Y. Hattori, 1999, Diabetes research and clinical practice.

[A case of mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS), showing temporary improvement during the treatment with eicosapentaenoic acid ethyl ester].

Y. Hattori, K. Nakajima, T. Eizawa, 2001, Rinshō shinkeigaku Clinical neurology.

The effect of long-term treatment with sulindac on the progression of diabetic retinopathy*

Motoji Naka, K. Hashizume, Y. Hattori, 2007, Current medical research and opinion.

Mitochondrial complex I activity is significantly decreased in a patient with maternally inherited type 2 diabetes mellitus and hypertrophic cardiomyopathy associated with mitochondrial DNA C3310T mutation: a cybrid study.

J. Hayashi, Y. Hattori, A. Sugiyama, 2006, Diabetes research and clinical practice.